中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 12
Dec.  2013
Turn off MathJax
Article Contents

Strengthening research on relationship between metabolic syndrome and chronic liver disease

DOI: 10.3969/j.issn.1001-5256.2013.12.001
  • Received Date: 2013-08-05
  • Published Date: 2013-12-20
  • Metabolic syndrome is becoming a global epidemic disease, and it has been an important cause or risk factor for chronic liver disease in China. Recently, many studies have shown that metabolic syndrome is not only the important cause or risk factor for non-alcoholic fatty liver disease, but also closely associated with increased incidence of cirrhosis and liver cancer in patients with alcoholic liver disease, chronic hepatitis B and C, and cryptogenic liver disease. Moreover, chronic liver disease patients with metabolic syndrome have a significantly increased risk of type 2 diabetes and arteriosclerotic cardiovascular disease. These results suggest that hepatologists should pay more attention to the clinical research on the relationship between metabolic syndrome and liver disease and its management.

     

  • loading
  • [1]FINUCANE MM, STEVENS GA, COWAN MJ, et al.National, regional, and global trends in body-mass index since 1980:systematic analysis of health examination surveys and epidemiological studies with 960 countryyears and“9.1”million participants[J].Lancet, 2011, 377 (9765) :557-567.
    [2]FAN JG.Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[J].J Gastroenterol Hepatol, 2013, 28 (Suppl 1) :11-17.
    [3]Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.
    [4] CHALASANI N, YOUNOSSI Z, LAVINE JE, et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J].Hepatology, 2012, 55 (6) :2005-2023.
    [5]NEWSOME PN, ALLISON ME, ANDREWS PA, et al.Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis[J].Gut, 2012, 61 (4) :484-500.
    [6]ALBELDAWI M, AGGARWAL A, MADHWAL S, et al.Cumulative risk of cardiovascular events after orthotopic liver transplantation[J].Liver Transpl, 2012, 18 (3) :370-375.
    [7]AGRAWAL S, DARUWALA C.Metabolic syndrome and hepatic resection:improving outcome[J].HPB (Oxford) , 2011, 13 (12) :846-859.
    [8]FAN JG, PENG YD.Metabolic syndrome and non-alcoholic fatty liver disease:Asian definitions and Asian studies[J].Hepatobiliary Pancreat Dis Int, 2007, 6 (6) :572-578.
    [9]FAN JG, CAI XB, LI L, et al.Alcohol consumption and metabolic syndrome among Shanghai adults:A randomized multistage stratified cluster sampling investigation[J].World J Gastroenterol, 2008, 14 (15) :2418-2424.
    [10]GUNJI T, MATSUHASHI N, SATO H, et al.Alcohol consumption is inversely correlated with insulin resistance, independent of metabolic syndrome factors and fatty liver diseases[J].J Clin Gastroenterol, 2011, 45 (9) :808-813.
    [11]O’SHEA RS, DASARATHY S, McCULLOUGH AJ.Alcoholic liver disease.AASLD practice guideline[J].Hepatology, 2010, 51 (1) :307-328.
    [12]JIA QY.Current situation of treatment of alcoholic liver disease[J].Jllin J Tradit Chin Med, 2012, 32 (5) :536-537. (in Chinese) 贾秋颖.酒精性肝病治疗现状[J].吉林中医药, 2012, 32 (5) :536-537.
    [13]KIM JH, KIM SY, JUNG ES, et al.Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients[J].Digestion, 2011, 84 (2) :149-155.
    [14]BUGIANESI E, SALAMONE F, NEGRO F.The interaction of metabolic factors with HCV infection:does it matter?[J].J Hepatol, 2012, 56 (Suppl 1) :s56-s65.
    [15]ADINOLFI LE, RESTIVO L, ZAMPINO R, et al.Chronic HCV infection is a risk of atherosclerosis.Role of HCV and HCV-related steatosis[J].Atherosclerosis, 2012, 221 (2) :496-502.
    [16]FAN JG, CHITTURI S.Hepatitis B and fatty liver:causal or coincidental?[J].J Gastroenterol Hepatol, 2008, 23 (5) :779-782.
    [17]HSU CS, LIU CH, WANG CC, et al.Impact of hepatitis B virus infection on metabolic profiles and modifying factors[J].J Viral Hepat, 2012, 19 (2) :e48-e57.
    [18]WONG VW, WONG GL, CHU WC, et al.Hepatitis B virus infection and fatty liver in the general population[J].J Hepatol, 2012, 56 (3) :533-540.
    [19]ZHANG Z, PAN Q, DUAN XY, et al.Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model[J].J Gastroenterol Hepatol, 2012, 27 (12) :1858-1864.
    [20]BORENA W, STROHMAIER S, LUKANOVA A, et al.Metabolic risk factors and primary liver cancer in a prospective study of 578, 700 adults[J].Int J Cancer, 2012, 131 (1) :193-200.
    [21]WELZEL TM, GRAUBARD BI, ZEUZEM S, et al.Metabolic syndrome increases the risk of primary liver cancer in the United States:a study in the SEER-Medicare database[J].Hepatology, 2011, 54 (2) :463-471.
    [22] SHI JP, LU L, QIAN JC, et al.Impact of liver steatosis on antiviral effects of pegylated interferon-alpha in patients with chronic hepatitis B[J].Chin J Hepatol, 2012, 20 (4) :285-288. (in Chinese) 施军平, 陆璐, 钱建成, 等.肝脂肪变对慢性乙型肝炎患者聚乙二醇干扰素α治疗临床疗效的影响[J].中华肝脏病杂志, 2012, 20 (4) :285-288.
    [23]FUNG J, YUEN MF, LAI CL.The role of steatosis in HBsAg seroclearance for patients with chronic hepatitis B infection:fact or fiction?[J].Dig Dis Sci, 2013, 58 (1) :20-22.
    [24]FAN JG, SAIBARA T, CHITTURI S, et al.What are the risk factors and settings of nonalcoholic fatty liver disease in Asia-Pacific[J].J Gastroenterol Hepatol, 2007, 22 (6) :794-800.
    [25]DUAN XY, QIAO L, FAN JG.Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma[J].Hepatobiliary Pancreat Dis Int, 2012, 11 (1) :18-27.
    [26]FAN JG, FARRELL GC;Asia-Pacific Working Party for Prevention of Hepatocellular Carcinoma.Prevention of hepatocellular carcinoma in non-viral related liver diseases[J].J Gastroenterol Hepatol, 2009, 24 (5) :712-719.
    [27] Expert Committee of Fatty Liver Disease, Chinese Medical Doctor Association.Expert recommendations for standardized management of fatty liver disease[J].J Clin Hepatol, 2013, 16 (3) :207-209. (in Chinese) 中国医师协会脂肪性肝病专家委员会.脂肪性肝病诊疗规范化的专家建议[J].实用肝脏病杂志, 2013, 16 (3) :207-209.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1994) PDF downloads(632) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return